MSB 3.21% $1.13 mesoblast limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-51

  1. 59 Posts.
    lightbulb Created with Sketch. 6
    Great pick. I am questioning competency of highly paid CFO/CS and SI’s oversight before providing go ahead to the filing of the 4C. Nothing new information. Expecting correction to 4C, same as previously and capital raise….further dilution. Current cash is estimated to last for next 8 quarters IF spending is kept at the same level or less. Still no BLC submission. Good scientist Bad CEO. Very disappointed!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.